Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.
Cortexyme Inc (CRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CRTX | AMGN | BMY | GILD | VRTX |
Company | Cortexyme Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
Open | 1.9100 | 261.97 | 56.98 | 90.68 | 410.71 |
High | 1.9700 | 264.25 | 57.05 | 90.68 | 412.36 |
Low | 1.8600 | 259.82 | 56.05 | 89.00 | 407.24 |
Last | 1.9500 | 264.21 | 56.81 | 89.14 | 412.11 |
Change | +0.0500 | +2.15 | -0.33 | -1.49 | +3.79 |
% Change | +2.63% | +0.82% | -0.58% | -1.64% | +0.93% |
Volume | 272,200 | 2,421,900 | 11,995,900 | 8,054,100 | 1,173,800 |
20-Day Average Volume | 311,120 | 3,692,505 | 11,675,340 | 6,373,685 | 1,954,515 |
Previous Close | 1.9000 | 262.06 | 57.14 | 90.63 | 408.32 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 2.1805 | 264.46 | 56.92 | 92.13 | 425.74 |
20-Day Raw Stochastic | 21.04% | 44.35% | 46.46% | 2.48% | 34.74% |
20-Day Relative Strength | 36.84% | 38.99% | 50.18% | 43.71% | 39.51% |
Weighted Alpha | -89.70 | -17.79 | +18.95 | +11.62 | -10.26 |
Today's Opinion | 100% Sell | 88% Sell | 40% Buy | 56% Buy | 88% Sell |
Previous Opinion | 100% Sell | 88% Sell | 88% Buy | 64% Buy | 88% Sell |
Last Month's Opinion | 100% Sell | 72% Sell | 100% Buy | 100% Buy | 24% Sell |
Performance | |||||
5-Days | |||||
%Chg | -5.80% since 07/22/22 | +1.37% since 12/31/24 | +0.44% since 12/31/24 | -3.50% since 12/31/24 | +2.34% since 12/31/24 |
Low | 1.7821 on 07/28/22 | 257.05 on 01/06/25 | 55.94 on 01/06/25 | 89.00 on 01/08/25 | 399.00 on 01/06/25 |
High | 2.0500 on 07/25/22 | 265.21 on 01/07/25 | 57.67 on 01/07/25 | 92.83 on 01/02/25 | 412.36 on 01/08/25 |
1-Month | |||||
%Chg | -13.72% since 06/29/22 | -3.07% since 12/06/24 | -4.33% since 12/06/24 | -3.25% since 12/06/24 | -10.82% since 12/06/24 |
Low | 1.7821 on 07/28/22 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.00 on 01/08/25 | 377.85 on 12/19/24 |
High | 2.5800 on 07/07/22 | 280.00 on 12/09/24 | 59.76 on 12/09/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
3-Month | |||||
%Chg | -46.72% since 04/29/22 | -16.83% since 10/08/24 | +8.25% since 10/08/24 | +4.61% since 10/08/24 | -10.20% since 10/08/24 |
Low | 1.7821 on 07/28/22 | 253.30 on 12/19/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 | 377.85 on 12/19/24 |
High | 4.0357 on 05/03/22 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
6-Month | |||||
%Chg | -67.39% since 01/28/22 | -15.17% since 07/08/24 | +42.06% since 07/08/24 | +31.96% since 07/08/24 | -14.48% since 07/08/24 |
Low | 1.7821 on 07/28/22 | 253.30 on 12/19/24 | 39.71 on 07/09/24 | 66.34 on 07/09/24 | 377.85 on 12/19/24 |
High | 7.2800 on 02/01/22 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 58,794 | 142,021,584 | 115,220,736 | 111,092,152 | 106,130,272 |
Shares Outstanding, K | 30,151 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
Annual Net Income | -89,950,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
Last Quarter Net Income | -21,641,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
60-Month Beta | 1.40 | 0.56 | 0.45 | 0.18 | 0.40 |
Per-Share Information | |||||
Most Recent Earnings | -0.72 on 05/10/22 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
Latest Earnings Date | 08/08/22 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | 0.770 on 12/13/24 | N/A |
Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 13.63 | 48.84 | 20.46 | 0.00 |